Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,11 M 17,43 M | CA 2019 | 22,25 M 30,35 M 20,27 M | Capitalisation | 49,96 M 68,15 M 45,51 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,11 M -32,8 M | Résultat net 2019 | -126 M -172 M -115 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,21 M 14,17 M | Dette nette 2019 | 5,22 M 7,12 M 4,76 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+35,04% | 5,92 Md | |
-15,13% | 4,51 Md | |
-9,75% | 3,15 Md | |
+2,14% | 3,1 Md | |
-6,82% | 2,42 Md | |
+47,87% | 1,97 Md | |
-7,89% | 1,68 Md | |
+0,09% | 1,65 Md | |
-12,97% | 1,53 Md |